Ignite Creation Date:
2025-12-25 @ 2:50 AM
Ignite Modification Date:
2025-12-31 @ 7:00 PM
Study NCT ID:
NCT04636333
Status:
UNKNOWN
Last Update Posted:
2022-03-31
First Post:
2020-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)
Sponsor:
Jiangsu Province Centers for Disease Control and Prevention
Organization:
Organization Data
Organization:
Class:
NETWORK
Study ID:
JSVCT096
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
NETWORK
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None